TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $1.09M2013: $407.0K2014: $2.15M2015: $4.96M2016: $10.19M2017: $2.79M2018: $4.08M2019: $24.83M2020: $43.91M2021: $73.09M2022: $116.12M2023: $44.00M2024: $7.00M2025: $6.00M$6.00M
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$6.00M-14.3%
2024$7.00M-84.1%
2023$44.00M-62.1%
2022$116.12M+58.9%
2021$73.09M+66.5%
2020$43.91M+76.8%
2019$24.83M+509.2%
2018$4.08M+45.9%
2017$2.79M-72.6%
2016$10.19M+105.6%
2015$4.96M+130.6%
2014$2.15M+428.0%
2013$407.0K-62.7%
2012$1.09M—